Sofinnova Venture Partners VIII, L.P., 10% Owner at Aclaris Therapeutics, Inc. (ACRS), bought 2,289,480 shares at $11.00 ($4.5M) on 2015-10-13, disclosed to the SEC on 2015-10-13.
Open-market purchase of $4.5M ACRS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,880,390 | $0 | 0.0% |
| 2 | $11.00 | 409,090 | $4.5M | 100.0% |
| Total | $1.97 avg | 2,289,480 | $4.5M | 100% |
| Filing → |
| VSAR | BUY | 2014-03-28 | $1.3M | — | Filing → |